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Abstract 
Recently we have proposed that similar to goal-directed and habitual action mediated by the 
fronto-striatal circuits, the fronto-striato-subthalamic-pallidal-thalamo-cortical network may 
also mediate goal-directed and habitual (automatic) inhibition in both the motor and non-motor 
domains (Jahanshahi, Obeso, Rothwell, & Obeso, 2015).  Within this framework, some of the 
clinical manifestations of Parkinson’s disease, dystonia, Tourette syndrome, and obsessive 
compulsive disorder can be considered to represent an imbalance between goal-directed and 
habitual action and inhibition.   It is possible that surgical interventions targeting the basal 
ganglia nuclei, such as deep brain stimulation of the subthalamic nucleus or the internal segment 
of the globus pallidus improve these disorders by restoring a functional balance between 
facilitation and inhibition in the fronto-striatal networks.  These proposals require investigation 
in future studies.  
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Introduction 
 
Inhibiting behaviour which is inappropriate in a particular context or socially unacceptable is a 
necessary feature of adaptive behaviour. Our daily lives are dotted with such inhibitory control: 
when dieting exerting self-control and not eating donuts made available at tea breaks, censoring 
and not expressing one’s true opinion to a senior colleague, not jumping the red light on the 
drive home. While the contribution of such inhibitory control to adaptive behaviour is perhaps 
underestimated because non-occurrence of behaviour is difficult to observe and quantify; 
nevertheless, it is likely that inhibitory processes operate across all domains: motor, cognitive 
and emotional.  Inhibition of motor responses, that is suppression of a movement or motor 
response that has been prepared or close to initiation and execution is perhaps the easiest to 
measure and for this reason the most widely investigated to date with the go nogo and the stop 
signal reaction time tasks.  Behavioural inhibition of inappropriate impulses or urges, cognitive 
inhibition (eg mental suppression of irrelevant information from memory) and emotional 
inhibition (eg inhibition of anxiety-provoking mental images) are more difficult to measure and 
study, but are also relevant to understanding inhibitory control for adaptive behaviour.  
 
Several types of behavioural inhibition have been distinguished (Aron, 2011; Verbruggen et al, 
2008; Jahanshahi et al, 2015). By contrast to automatic inhibition, volitional inhibition is 
intentional, controlled and effortful (Verbruggen & Logan, 2008; Zandbelt & Vink, 2010).  
However, the automatic-volitional inhibition distinction is not fixed, since volitional inhibition 
has been shown to be triggered by masked ‘no go’ stimuli of which the person is not overtly 
aware (van Gaal et al, 2010)  and through learning, volitional inhibition can become automatic 
(Verbruggen et al, 2014). Another common distinction is between reactive inhibition triggered 
by external stimuli (eg stopping car at red traffic light) and proactive inhibition which is 
prospective and necessary for achieving goals and self-control over drinking, eating, smoking, 
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etc. (Aron, 2011).  Somewhat overlapping with and encompassing the above two sets of 
distinctions, are the concepts of goal-directed versus habitual/automatic inhibition (Jahanshahi 
et al, 2015).  Goal-directed inhibition (for example, not smoking when trying to quit) is mainly 
volitional, intentional and proactive in the service of a specific goal achievement; whereas 
habitual inhibition (for instance, not swearing in public) is developed through practice and 
education, largely stimulus-driven and automatic (Jahanshahi et al, 2015).  Global (eg freezing 
when faced with a grizzly bear in a wood) versus selective (eg stopping singing while coninuing 
to play the piano) inhibition has been a further distinction (Aron, 2011).  The indirect and direct 
cortico-basal ganglia pathways considered to respectively mediate proactive and reactive 
inhibition are shown in Figure 1.   
 
Figure 1 about here 
 
 
One of the executive functions of the frontal cortex is inhibitory control, with the inferior frontal 
cortex (Aron, 2014), the dorsolateral prefrontal cortex (Diamond, 1996), the orbitofrontal 
cortex (Iversen et al, 1970;  Dias et al, 1996) and the SMA (Aron & Poldrack, 2006; Aron et al, 
2007) playing a role in inhibition.  A wealth of information is now available supporting the role 
of the basal ganglia, particularly the subthalamic nucleus and the striatum in inhibition 
including evidence from lesion (eg Eagle et al, 2008; Baunez et al, 1995) and 
electrophysiological (eg Yoshida & Tanaka, 2009; Isoda & Hikosaka, 2008; Schmidt et al, 
2013) studies in animals, functional imaging studies in humans (Aron & Poldrack, 2006; Aron 
et al, 2007; Rae et al, 2015; Zandbelt et al, 2013; Chikazoe et al, 2009; Schel et al, 2014), 
behavioural and imaging investigations in Parkinson’s disease (Gauggel et al, 2004; Obeso et 
al, 2011, Ye et al, 2014; Vriend et al, 2015) assessment of the effects of surgical treatment of 
PD with subthalamotomy (Obeso et al, 2014; Bickel et al, 2010) or deep brain stimulation of 
the subthalamic nucleus (Jahanshahi et al, 2000; Frank et al, 2007; Wylie et al, 2010; Hershey 
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et al, 2004; Ballanger et al, 2009; Obeso et al, 2013; Pote et al, 2016) and recordings of local 
field potentials from the implanted electrodes after surgery (Ray et al, 2012; Alegre et al, 2013; 
Benis et al, 2014).  From a review of this evidence Jahanshahi et al (2015) proposed that the 
fronto-striato-subthalamic-pallidal network are involved in goal-directed and habitual 
inhibition.  This parallels the role of these circuits in goal-directed and habitual action, 
respectively mediated by the associative and motor fronto-striatal circuits (Balleine & 
O’Doherty, 2010; Graybiel, 2008).  With repetition and practice, both initiation and inhibition 
of action can shift from goal-directed to habitual/automatic, which frees up attentional resources 
and allows for concurrent engagement in other tasks. Goal-directed but not habitual actions are 
sensitive to outcome devaluation and it needs to be established if outcome sensitivity is also a 
criterion that distinguishes goal-directed inhibition from habitual inhibition and to identify 
other relevant criteria.     
 
 
Lack of behavioural inhibition can manifest itself as disinhibition, impulsivity, and 
perseveration, all of which are characteristic of patients with frontal lesions.  Impulsivity, can 
manifest itself as delay aversion or an inability to take time to reflect or defer decisions, actions 
or gratification (Evenden, 1999). Impulsivity is among the diagnostic criteria for attention 
deficit hyperactivity disorder, substance abuse and trichotillomania and can also feature in 
mania. In this paper, we consider the relevance of inhibition to some of the clinical 
manifestations of a number of primarily basal ganglia disorders, namely, Parkinson’s disease, 
dystonia, Tourette syndrome and obsessive–compulsive disorder. For each disorder, we will 
consider the specific clinical manifestations that reflect failure of inhibitory processes and then 
the empirical evidence for deficits in inhibition on experimental tasks or from imaging studies.   
Parkinson’s Disease 
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Parkinson’s disease (PD) is a movement disorder, characterized by the primary motor 
symptoms of akinesia, bradykinesia, tremor, rigidity, postural instability and gait problems and 
a host of non-motor symptoms including cognitive deficits, psychiatric problems such as 
depression, apathy, anxiety hallucinations and delusions.  According to the classical models, 
dopamine depletion in PD is associated with underactivity of the direct and overactivity of the 
indirect pathway, which results in excessive inhibitory output from the basal ganglia to motor, 
premotor and prefrontal cortical areas and to the brainstem (Albin et al, 1989; De Long, 1990). 
This excessive inhibitory output from the basal ganglia is considered responsible for akinesia, 
characterized by the reduction or absence of a range of normally automatic movements such as 
blinking, facial expression, gesturing, turning in bed, arm swinging, and handwriting in PD, 
which represents over-inhibition of habitual movements.  Lesioning or deep brain stimulation 
of the subthalamic nucleus (STN) or the internal segment of the globus pallidus (GPi) reduces 
this excessive inhibitory output and improves akinesia (ADD REFs     ).  
 
Patients with PD have deficits in inhibitory control on a host of cognitive tasks requiring 
inhibition of prepotent or habitual responses such as the Stroop, random number generation and 
the Hayling sentence completion test (eg Obeso et al, 2011).  Deficits in inhibitory control are 
also present in PD relative to age-matched controls on go nogo,  stop signal reaction time tasks, 
anti-saccade and Eriksen flanker tasks (Beste et al, 2009; Gauggel et al, 2004;  Obeso et al, 
2011; Chan et al, 2005; Praamstra & Plat, 2001).  On the stop signal task requiring motor 
inhibition, medicated or de novo never medicated patients with PD have prolonged stop signal 
reaction times indicative of delayed inhibition and this is associated with reduced task-related 
activation of he inhibition network, including the inferior frontal gyrus (Ye et al, 2014; Vriend 
et al, 2015). 
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With progression of the illness, freezing of gait, episodes marked by a temporary motor block 
during walking, can be experienced by people with PD, triggered by turning, fatigue, confined 
spaces and stressful situations  (Rahman et al, 2008), During freezing episodes patients are 
unable to initiate a step despite the intention to do so, and they report that their feet feel as if 
they are glued to the floor.  Such freezing represents excessive motor inhibition (Jahanshahi et 
al, 2015; Lewis and Shine, 2016). It is possible that inhibitory output from the substantia nigra 
pars reticulata (SNr) and supplementary motor area (SMA) to the mesencephalic locomotor 
region could be involved, since these areas can suppress locomotion in animal models (Snijders 
et al, 2016). From a review of the imaging studies of freezing of gait in PD (Fasano et al, 2015), 
disruptions in the ‘executive attention’ network and tissue loss in the premotor cortex, inferior 
frontal gyrus, precentral gyrus, parietal and occipital areas of the right hemisphere were noted, 
areas which are involved not only in visuospatial function but also in inhibitory control. In 
addition, involvement of the caudate nucleus and the locomotor centres in the brainstem in 
freezing of gailt was also identified.  These findings, particularly grey matter atrophy in the 
inferior frontal gyrus (Kostic e al, 2012) and hypoactivation of the SMA and posterior parietal 
regions and overactivation of the mesencaphalic locomotor regions during motor imagery of 
walking (Snijders et al, 2011) in patients with freezing of gait are consistent with excessive 
inhibition of locomotion triggered by conflictual visual information.   The hypothesis that the 
episodic motor blocks during walking characteristic of freezing of gait reflect excessive 
inhibition due to dysfunction of the cortical (SMA, inferior prefrontal cortex) and subcortical 
(caudate, SNr) areas engaged in inhibitory control, particularly triggered in situations when 
concurrent executive control of attention and gait are necessary, requires direct investigation in 
future studies.  There is some preliminary support for this proposal from studies showing 
deficits in inhibitiory control in patients with Parkinson’s disease and freezing of gait on the 
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stop signal task (Bissett et al, 2015;  Georgiades et al, 2016), which becomes more pronounced 
with the addition of a cogntive load (Georgiades et al, 2016).   
 
Apathy is a common psychiatric problem in PD (Aarsland et al, 1999; Pagonabarraga et al, 
2015).  It is a multi-dimensional syndrome with cognitive, emotional and behavioural 
components, whereby patients lack motivation, interest, concern, emotional reactivity and show 
no initiative or spontaneous activity and often report being devoid of thoughts and emotions. 
The biological basis of apathy remains unclear, with both dopaminergic and serotonergic 
systems implicated (Sanatangelo et al, 2015a; Maillet et al, 2016).  It is possible that excessive 
inhibition in the motor and non-motor domains mediated through the fronto-basal ganglia 
circuits contributes to the development of apathy in PD (Jahanshahi et al, 2015).  In support of 
this proposal, there is imaging evidence of decreased grey matter volume in the right SMA, the 
right inferior frontal gyrus, the left orbitofrontal cortex, left inferior and superior parietal areas 
and the nucleus accumbens bilaterally in non-depressed PD patients with apathy relative to 
those without apathy (Martinez-Hora et al, 2016 ).  .Other imaging evidence also implicate the 
right caudate or ventral striatum and the inferior frontal gyrus in apathy in PD.  Compared to 
PD patients without apathy, de novo untreated non-depressed and non-depressed PD patients 
with apathy had lower dopamine transporter levels in the striatum, particularly the right caudate 
(Santangelo et al, 2015a) and reduced metabolism in the right ventral striatum prior to surgery 
predicted development of apathy following STN DBS surgery (Robert et al, 2014).  
Furthermore, imaging has identified an association between apathy in PD and right hemispheric 
metabolism in the inferior frontal gyrus, middle frontal gyrus and the anterior insula (Robert et 
al, 2012) and in another study reduced grey matter volume in the inferior frontal gyrus 
bilaterally was among the areas which correlated with high apathy scores in PD (Reijnders  et 
al, 20 10). Some of these areas overlap with the brain inhibitory network, and their volume 
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reduction may contribute to the reduction of spontaneous and self-generated activity and 
motivational deficits in PD patients with apathy. Also of interest, is the finding from a 
longitudinal study that in de novo PD patients, reduced performance on the Stroop interference 
task which requires inhibitiory control and engages medial prefrontal areas, predicted 
subsequent development of apathy (Santangelo et al, 2015b).   
 
At the other extreme, some medication-related complications of PD can be considered as 
reflecting disinhibition of the networks involved in motor and non-motor inhibition.  
Dopaminergic medication used in the treatment of PD, can give rise to levodopa-induced 
dyskinesias (LIDs) and impulse control disorders (ICDs).  Both LIDs and ICDs may represent 
failures of habitual or automatic inhibition (Jahanshahi et al, 2015).   With LIDs, failure of 
automatic inhibition may result in fragments of movement and stereotyped behaviours being 
released.  Recent imaging evidence has implicated the inferior frontal gyrus and the 
supplementary motor area, two key nodes in the motor inhibitory network, in dyskinesias (Herz 
et al, 2014; Cerasa et al, 2012; 2015a), leading to the proposal that dysfunction of the neural 
network mediating motor inhibition may also induce LIDs.  For example, in the on medication 
state, for patients with LIDs the right inferior frontal cortex showed decreased functional 
connectivity with the motor cortex and increased connectivity with the putamen compared to 
patients with no LIDs (Cerasa et a, 2015a).  This was interpreted as reflecting reduced inhibitory 
control from the right inferior frontal gyrus over the motor cortex in the on state, giving rise to 
LIDs. Furthermore, it has been shown that in PD patients with LIDs, intake of levodopa 
medication tended to make inhibitory control and monitoring of failures of inhibition during a 
stop signal motor inhibition task worse, which fMRI showed to be associated with decreased 
activity of the right inferior frontal cortex during motor inhibition, whereas patients without 
LIDs showed the reverse (Cerasa et al, 2015b).  
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A range of ICDs, including hypersexuality, pathological gambling and shopping, overeating, 
and punding develop in about 25% of people with PD treated with dopamine agonists or 
levodopa (Weintraub et al, 2015).  As a result of deficient habitual/automatic inhibition, patients 
with ICDs respond excessively to rewarding stimuli associated with sex, food, money, or 
shopping.  PD patients with ICDs show impulsive choice on delay discounting tasks, preferring 
small immediate rewards to larger delayed rewards (Voon et al,  2010). Imaging has revealed 
that dopaminergic medication results in differential patterns of activation in brain areas 
implicated in response inhibition and impulse control particularly the lateral orbitofrontal 
cortex, rostral cingulate, amygdala and exernal segment of the globus pallidus (GPe) in PD 
patients with (decreased dopamine induced activation) or without (increased dopamine induced 
activation) ICDs such as pathological gambling (van Eimeren et al, 2010).  Enhanced sexual 
desire and increased activation in the ventral striatum, anterior cingulate cortex and 
orbitofrontal cortex was reported in response to sexual cues for PD patients with hypersexuality 
relative to patients without such ICDs (Politis et al, 2013).   Thus ICDs in PD reflect impulsive 
choice and behaviour due to failure of habitual inhibition.  Cognitive behaviour therapy has 
some success in helping PD patients with ICDs to proactively impose goal-directed inhibition 
over their impulsive behaviour, but response to this can be variable (Okai et al, 2015).  
Dystonia 
Dystonia is a hyperkinetic movement disorder.  The latest expert classification has defined it as 
“a movement disorder characterized by sustained or intermittent muscle contractions causing 
abnormal, often repetitive, movements, postures, or both. Dystonic movements are typically 
patterned, twisting, and may be tremulous. Dystonia is often initiated or worsened by voluntary 
action and associated with overflow muscle activation.” (Albanese et al, 2013).  The abnormal 
contractions can affect muscles of the eyes (blehparospasm), face and jaw (oromandibular 
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dystonia), larynx (spadmodic dysphonia), neck (cervical dystonia), hand during writing 
(writer’s cramp).  Dystonia can be focal, affecting only one part of the body, segmental (2 
adjacent body parts affected), multifocal, hemi-dystonia (one side of body), or generalized 
(involving the trunk and two other body parts).  
The exact cause of dystonia is not known. Dystonia is considered a movement disorder 
associated with dysfunction of the basal ganglia (Berardelli et al., 1998; Marsden, 1976), and 
more recently, cerebellar involvement in dystonia has also been documented (Delmaire et al, 
2007; Jinnah & Hess, 2006; Neychev et al, 2008).  Many genes causing various forms of 
dystonia in association with environmental triggers have been identified (Fuchs & Ozelius, 
2011 ). 
 
According to the classical De Long (1990) and Albin, et al (1990) models, hyperkinetic 
movement disorders such as dystonia are associated with reduced inhibitory output from the 
GPi, which gives rise to increased thalamic and cortical activation. There is some support for 
this model from hyperkinetic transgenic mice model of DYT1 dystonia (e.g., Chiken, 
Shashidharan, & Nambu, 2008) and neuronal recordings from the GPi of patients with dystonia 
undergoing DBS surgery (e.g., Vitek et al, 1999), but the improvement of dystonia with GPi 
DBS (Vidailhet et al, 2007), which reduces the activity of the GPi are not consistent with the 
classical “rate” models.    
 
Imaging studies have shown movement-related overactivity of the dorsolateral prefrontal 
cortex, the anterior cingulate cortex, the SMA and the lenticular nuclei, and underactivation of 
the primary motor cortex in dystonia (e.g., Ceballos-Baumann et al., 1995; Dresel, et al, 2006).  
Using different TMS protocols, reduced cortico–cortical inhibition (Edwards et al, 2003;  
Ridding et al, 1995) and increased plasticity (e.g., Quartarone et al., 2003) have been 
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demonstrated in dystonia.  This loss of inhibition, particularly loss of ‘surround inhibition’, is 
considered responsible for loss of selectivity and overflow of activation to other muscles.  The 
essence of ‘surround inhibition’ is that muscles that are not actively involved in producing a 
movement are inhibited during the movement.  Surround inhibition can be demonstrated with 
TMS and in focal hand dystonia it has been shown that surround inhibition is deficient (Sohn 
& Hallett, 2004; Beck et al, 2008; Stinear & Byblow, 2004a).  This loss of selectivity in muscle 
activation has been demonstrated even when patients imagined making specific movements 
(Quartarone et al, 2005).  The loss of inhibition in dystonia is also associated with a delay in 
the ability to inhibit preplanned responses and patients required longer warning times than 
healthy controls to be able to do so (Stinear & Byblow, 2004b).  It has been suggested that some 
of the sensory deficits such as increased spatial (Tinazzi et al, 2002) and temporal (Fiori et al , 
2003) discrimination thresholds may reflect deficient lateral inhibition.  These deficits and 
impairment of senorimotor integration (Kaji et al, 1995; Murase et al, 2000) in dystonia, as well 
as the inceased plasticity may all result from the loss of inhibition which could itself be due to 
a reduced number of inhibitory interneurons (Hallett, 2011).  These hypotheses require 
verification in future investigations. 
Tourette syndrome 
Tourette syndrome (TS) is characterized by motor and/or vocal tics, the latter often consisting 
of obscene words.  TS is frequently accompanied by comorbidites such as attention deficit 
hyperactivity disorder, depression, obsessive compulsive behaviours, and self-injurious 
behaviours.  Tics are involvuntary movements or vocalizations, but are often preceded by a 
premonitory sensation and urge, and patients describe a sense of relief after performing the tic.  
Patients with TS can suppress the tics temporaily and thus can impose goal-directed intentional 
inhibition to suppress their involuntary tics for brief periods.   
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TS has been considered a basal ganglia disorder of inhibition (Mink, 2001).  Mink (2001) 
proposed that repeated inappropriate activation of striatal neurons, leads to inhibition of the 
internal segment of the globus pallidus (GPi) and the substantia nigra reticulata (SNr), the 
output pathways of the basal ganglia, which would normally be tonically active to prevent 
unwanted movements, and that this GPi/SNr inhibition leads to a disinhibition of thalamo-
cortical targets and generates tics.   Evidence from imaging and neuropathological studies 
implicate the cortico-basal ganglia circuits and abnormal distribution of inhibitory interneurons 
in the basal ganglia in TS (McNaught & Mink, 2011; Kalanithi et al, 2005; Worbe et al, 2015).  
On behavioural tasks that assess inhibitory control, the evidence in TS is inconsistent, with 
some suggesting failure of inhibition (Channon et al, 2004; Wylie et al, 2013), others not 
finding such deficits (Roessner et al, 2008) and even reporting enhanced cognitive and 
inhibitory control in TS (Mueller et al, 2006), due to development of compensatory mechanisms 
to counteract the lack of inhibition. The neural correlates of intentional suppression of tics in 
TS have been investigated in several imaging studies.  Success in intentional inhibition of tics 
by TS patients was found to be associated with a significant increase in a measure of local 
connectivity in the inferior frontal gyrus  (Ganos et al, 2014). In another study, comparison of 
tic suppression with a ‘free-ticcing’ state was associated with significant activation of the 
prefrontal cortex, anterior cingulate cortex, caudate and putamen (Peterson et al, 1998).  
Compared to age-matched healthy controls, people with TS showed greater activaion of the 
frontal cortex and caudate during suppression of the urge to blink (Mazzone et al, 2010).  These 
results indicate the central role of the basal ganglia and the frontal cortex in volitional and 
intentional tic suppression in TS.  By exerting voluntary effort, goal-directed inhibition 
mediated by the frontal cortex, anterior cingulate cortex and the caudate, can be mobilized by 
patients with TS to suppress tics.  Deep brain stimulation of the GPi or the nucleus accumbens 
(Welter et al, 2008; Neuner et al, 2009; Kefalopolou et al, 2015), may control tics by restoring 
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the balance between facilitation and inhibition in the cortico-basal ganglia circuits.  It was 
proposed that spontaneous tics emerge either by overactivity in the generation of habitual 
actions or reduced activation of the mechanisms of habitual/automatic inhibition (Jahanshahi 
et al, 2015).   
  
Obsessive compulsive disorder 
People with obsessive compulsive disorder (OCD) experience intrusive unwanted thoughts and 
images (obsessions) and repetitive behaviours (compulsions), which are driven by doubt, 
exaggerated perceptions of danger and anxiety. Different types of repetitive behaviour may be 
engaged in including washing, checking, or hoarding.  Imaging studies have established 
hyperactivity of the orbitofrontal cortex-caudate circuit in people with OCD, which is increased 
by symptom provocation and conversely reduced by successful treatment (Milad & Rauch, 
2012; Chamberlain et al, 2005; Eng, Kim & Chen, 2015).  The orbitofrontal cortex not only 
plays a role in detecting motivational value and salience of stimuli (Kringelbach, 2005), but 
also mediates inhibition as its lesioning in animals results in perseveration (Iversen et al, 1970; 
Dias et al, 1996).     
 
Other imaging evidence also supports inhibitory failure in OCD. During performance of a ‘go 
nogo’ task which requires action restraint/inhibition on no go trials, a negative association 
between severity of OCD symptoms and inhibition-related acivation of the orbitofrontal cortex 
was found (Roth et al, 2007).  A meta-analysis of imaging studies in OCD revealed that these 
patients show reduced activation in the caudate and putamen during performance of inhibition 
and interference tasks and reduced activation of the inferior frontal gyrus, anterior cingulate 
corex, medial frontal cortex, dorsolateral prefronal cortex and caudate during switching tasks 
(Eng et al, 2015).  A recent imaging study (Banca et al, 2015) demonstrated that during 
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exposure to symptom provoking stimuli, OCD patients had deactivation of the caudate-
prefrontal circuits together with hyperactivation of the STN and putamen which were 
interpreted as reflecting a dissociation between areas involved in goal-directed versus habitual 
behaviours respectively.  This study also showed hyperactivity of the putamen during symptom 
provocation and subsequent putaminal deactivation during avoidance of the provoking stimuli 
and relief, indicating that the putamen may play a significant role in habit formation in OCD 
(Banca et al, 2015).   OCD patients were more prone to ‘slips of action’ indicative of over-
reliance on habits and were deficient in goal-directed control on an instrumental learning task 
(Gillan, 2011).  OCD patients also develop excessive avoidance habits on a shock avoidance 
task (Gillan et al, 2014).  On the basis of these results, OCD has been formulated as a shift from 
goal-directed to habitual responding (Gillan et al, 2011; 2015; Banca et al, 2015).  However, in 
light of the fact that patients with OCD can temporarily exert goal-directed inhibition to control 
their compulsive behaviours, it is likely that failure of habitual/automatic inhibition of 
unwanted and intrusive thoughts and images and emotions may play a role in the genesis of 
obsessions and compulsions.   OCD is characterized by an imbalance between goal-directed 
and habitual action and inhibition (Jahanshahi et al, 2015).  Successful treatment of OCD with 
deep brain stimulation of several targets including the ventral internal capsule and ventral 
striatum (Greenberg et al, 2010), the nucleus accumbens (Huff et al, 2010)  or the STN (Mallet 
et al, 2008) has been documented.  In an imaging study of operated OCD patients, acute DBS 
in the ventral caudate and ventral striatum was associated with activation of the prefrontal 
cortex, anterior cingulate cortex, putamen and globus pallidus (Rauch et al, 2006).  Thus DBS 
may improve OCD symptoms by modulating the dysfunctional network in the disorder which 
overlaps with the inhibitory network, which may in turn restore the balance between goal-
directed and habitual action and inhibition.   
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Conclusions 
The basal ganglia are phylogenetically ancient structures whose basic organisational principle 
has remained unchanged for many millions of years (Stephenson-Jones et al, 2011). In the 
lamprey, the basal ganglia have inhibitory projections to brainstem nuclei that appear to form 
the basis for action selection through release of inhibition, and it has been suggested 
(Stephenson-Jones et al, 2011) that such an organisational arrangement has been co-opted in 
higher primates to control multiple cognitive, emotional and motor functions in a broad range 
of behaviours. Although the work above suggests that this basic tenet is correct, the range of 
control has expanded considerably, to distinguish, e.g. proactive and reactive control or habitual 
and goal directed inbitory control of behaviour. The complexities that these additional functions 
require may explain the wide variety of pathologies of control that can be observed.  It remains 
to be clarified how the recently elucidated ‘pause then cancel’ model of stopping, with the 
subthalamic-SNr ‘pause’ and an arkypallidal-striatal ‘cancel’ components (Schmidt & Derke, 
2016, this issue) contribute to some of the clinical manisfestions of basal ganglia disorders 
outlined above.  
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Figure 1: The cortico-basal ganglia pathways involved in proactive and reactive inhibition. 
With proactive and reactive inhibition respectively via the indirect fronto-striato-pallido-
thalamo-cortical pathway and the hyperdirect cortico-subthalamic-pallidal-thalamo-cortical 
pathways. (with permission from Jahanshahi et al, 2015). IFC: inferior frontal cortex, pre-
SMA: pre supplementary motor area, DLPFC: dorsolateral prefrontal cortex, GPI: internal 
segment of globus pallidus, GPe: external segment of globus pallidus, SNr: substantia nigra 
pars reticulata.  Some connections are not shown. 
 
 
 
 
 
